Home » Ranbaxy Plans to Re-Launch Skincare Brand Sotret in U.S.
Ranbaxy Plans to Re-Launch Skincare Brand Sotret in U.S.
India’s largest drug maker Ranbaxy Laboratories plans to re-launch its former flagship skincare brand Sotret (isotretinoin) in the U.S., that has been banned for almost four years, through a marketing partnership with a Canadian firm Cipher Pharmaceuticals.
The Economic Times
The Economic Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May